top of page
HOME
PORTFOLIO
TEAM
CONTACT
More
Use tab to navigate through the menu items.
Portfolio
Acquired by Kala Pharmaceuticals
NASDAQ: KALA
Acquired by Novartis, June 2022
bottom of page
